|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial显示文摘 | Eric Lawitz Fred F Poordad Phillip S Pang Robert H Hyland Xiao Ding Hongmei Mo William T Symonds John G McHutchison Fernando E Membreno | 2013 | The Lancet2013，，： | 5 |
| 2 | Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial显示文摘 | Kris V Kowdley Eric Lawitz Israel Crespo Tarek Hassanein Mitchell N Davis Michael DeMicco David E Bernstein Nezam Afdhal John M Vierling Stuart C Gordon Jane K Anderson Robert H Hyland Hadas Dvory-Sobol Di An Robert G Hindes Efsevia Albanis William T Symo | 2013 | The Lancet2013，，9883： | 3 |
| 3 | Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis显示文摘 | Lawitz E Poordad F Brainard DM | 2015 | Hepatol2015，61，3： | 1 |
| 4 | Peginterferon al- fa-2b or alfa-2a with ribavirin for treatment of hepatitis C infec- tion显示文摘 | McHutchison JG Lawitz E J Shiffman ML | 2009 | N Engl J Med2009，361，6： | 1 |
| 5 | Peginter- feron alfa-2b or alfa -2a with ribavirin for treatment of hepati- tis C infection显示文摘 | McHutchison J G Lawitz E J Shiffman M L | 2009 | N Engl J Med2009，361，6： | 1 |
| 6 | Treatment of HCV infection by targeting microRNA显示文摘 | Janssen H L Reesink H W Lawitz E J Zeuzem S Ro- driguez-Torres M Patel K van der Meer A J Patick A K Chen A Zhou | 2013 | New England J Med2013，368，18： | 1 |
| 7 | Sofosbuvir for previ- ously untreated chronic hepatitis C infection显示文摘 | Lawitz E Mangia A Wyles D | 2013 | N Engl J Med2013，368，20： | 1 |
| 8 | Sofosbuvir for previ- ously untreated chronic hepatitis C infection 显示文摘 | Lawitz E Mangia A Wyles D | 2013 | N Engl J Med2013，368，20： | 1 |
| 9 | A randomized, double-blind, placebo-controlled assessment of BMS:936558, a fully humanmonoclonal antibody to programmed death-1 (PD- 1 ), in patients with chronic hepatitis C virus infection 显示文摘 | Gardiner D Lalezari J Lawitz E | 2013 | PLoS One2013，8，63： | 1 |
| 10 | Sofosbuvir for previously untreated chronic hepatitis C infection显示文摘 | Lawitz E Mangia A Wyles D | 2013 | N Engl J Med2013，368，20： | 1 |
| 11 | HCV SPRINT-1 final results: SVR 24 from a phase 2 study of boceprevir plus PeglFN alpha-2b/ribavirin in treatment-naive subjects with genotype 1 chronic hepatitis显示文摘 | Kwo P Lawitz E J McCone J | 2009 | J Hepatol2009，50，1： | 1 |
| 12 | Treatment of HCV infection by targeting microRNA 显示文摘 | Janssen HL Reesink HW Lawitz E J | 2013 | New England Journal of Medicine2013，368，18： | 1 |
| 13 | Safety and antiviral activity of ANA598 in combination with pegylated interferon α2A plus ribavirin in treatment-naive genotype-1 chronic HCV patients显示文摘 | Lawitz E Rodriquez-Torres M Rustgi VK | | 0，，1： | 1 |
| 14 | Sofosbuvir for previously untreated chronic hepatitis C infection显示文摘 | Lawitz E Gane EJ | 2013 | N Engl J Med2013，368，20： | 1 |
| 15 | Sofosbuvirforpreviously untreated chronic hepatitis C infection显示文摘 | LAWITZ E MANGIAA WYLES 0 etal | 2013 | N EnglJ Med2013，368，20： | 1 |
| 16 | Efficacy and safety of albinterferon alfa-2b in combination with ribavirin in treatment-naive,chronic hepatitis C genotype 1 (CHC Gl) patients显示文摘 | Zeuzem S Sulkowski M Lawitz E | | Journal of Hepatology0，，： | 1 |
| 17 | Short-term antiviral activity and safety of ACH-806 (GS-9132), an NS4A antagonist, in HCV genotype 1 infected individuals显示文摘 | Pottage J Lawitz E Mazur D | 2007 | J Hepatol2007，46，1： | 1 |
| 18 | Interferon-free, direct-acting antiviral therapy for chronic hepatitis C显示文摘 | GUTIERREZ JA LAWITZ E J POORDAD F | 2015 | Viral Hepat2015，2201，： | 1 |
| 19 | E fficacy and safety of weight-based regimens of taribavirin or ribavirin,given with peginterferon alfa-2b,at 12 weeks after treatment (svrl2) in naive patients with genotype 1 chronic-hepatitis C显示文摘 | Poordad F Lawitz E Pozza R | | Journal of Hepatology0，，： | 1 |
| 20 | Preliminary study of two antivi- ral agents for hepatitis C genotype 1 显示文摘 | Lok A S Gardiner D F Lawitz E | 2012 | N Engl J Med2012，366，21： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员